N = 19 | |
---|---|
Chemotherapy | |
Cisplatin + Vinorelbine | 18 (94.7%) |
3 cycles | 2 |
4 cycles | 16 |
Cisplatin + Docetaxel | 1 (5.3%) |
4cycles | 1 |
Thoracic radiotherapy | |
60 Gy completed | 19 (100%) |
Without discontinuation | 10 |
With discontinuation | 9* |
Local consolidative therapy | |
Brain | 9 (47.4%) |
Surgery | 1 |
Surgery + whole-brain radiotherapy | 3 |
Stereotactic irradiation | 5 |
Bone | 7 (36.8%) |
Radiotherapy | 7 |
Adrenal grand | 2 (10.5%) |
Surgery | 1 |
Radiotherapy | 1 |
Cervical lymph node | 1 (5.3%) |
Surgery + radiotherapy | 1 |